Thermo Fisher Scientific (TMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2018 | 06-2018 | 03-2018 | 12-2017 | 09-2017 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,098,000 | 937,000 | 950,000 | 1,335,000 | 741,100 |
| Receivables | 4,257,000 | 4,441,000 | 4,530,000 | 3,879,000 | 4,209,100 |
| Inventories | 2,982,000 | 2,866,000 | 2,891,000 | 2,971,000 | 3,125,500 |
| Other current assets | 1,229,000 | 1,230,000 | 1,217,000 | 1,236,000 | 768,300 |
| TOTAL | $9,566,000 | $9,474,000 | $9,588,000 | $9,421,000 | $8,844,000 |
| Non-Current Assets | |||||
| PPE Net | 3,978,000 | 3,952,000 | 4,059,000 | 4,047,000 | 3,931,600 |
| Intangibles | 40,361,000 | 40,800,000 | 41,755,000 | 41,974,000 | 42,158,500 |
| Other Non-Current Assets | 1,173,000 | 1,177,000 | 1,178,000 | 1,227,000 | 1,051,200 |
| TOTAL | $45,512,000 | $45,929,000 | $46,992,000 | $47,248,000 | $47,141,300 |
| Total Assets | $55,078,000 | $55,403,000 | $56,580,000 | $56,669,000 | $55,985,300 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,344,000 | 1,359,000 | 1,354,000 | 1,428,000 | 1,123,800 |
| Accrued Expenses | 817,000 | 755,000 | 643,000 | 918,000 | 771,100 |
| Other current liabilities | 797,000 | 816,000 | 909,000 | N/A | N/A |
| TOTAL | $5,196,000 | $5,980,000 | $7,072,000 | $7,048,000 | $7,031,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | 17,760,000 | 17,709,000 | 18,122,000 | 18,873,000 | 21,117,600 |
| Deferred Revenues | N/A | N/A | N/A | 719,000 | 747,300 |
| Other Non-Current Liabilities | 2,682,000 | 2,670,000 | 2,657,000 | 2,569,000 | 0 |
| TOTAL | $22,992,000 | $22,978,000 | $23,385,000 | $24,208,000 | $24,252,200 |
| Total Liabilities | $28,188,000 | $28,958,000 | $30,457,000 | $31,256,000 | $31,283,500 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 402,576 | 402,796 | 402,323 | 401,784 | 400,995 |
| Common Shares | 431,000 | 430,000 | 429,000 | 428,000 | 428,000 |
| Retained earnings | 17,866,000 | 17,226,000 | 16,542,000 | 15,914,000 | 15,445,800 |
| Other shareholders' equity | -2,519,000 | -2,491,000 | -2,042,000 | -2,003,000 | -2,183,000 |
| TOTAL | $26,890,000 | $26,445,000 | $26,123,000 | $25,413,000 | $24,701,800 |
| Total Liabilities And Equity | $55,078,000 | $55,403,000 | $56,580,000 | $56,669,000 | $55,985,300 |